Brief: Kronos Bio Announces Discovery Collaboration With Genentech
09/01/2023 12:16
Jan 9 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO ANNOUNCES DISCOVERY COLLABORATION WITH
GENENTECH TO
ADVANCE NOVEL THERAPIES AGAINST TRANSCRIPTIONAL TARGETS IN
ONCOLOGY
* KRONOS BIO INC - WILL RECEIVE A $20 MILLION UPFRONT
PAYMENT AND
COULD RECEIVE UP TO AN ADDITIONAL $554 MILLION IN MILESTONE
PAYMENTS
* KRONOS BIO INC - AGREEMENT WILL LEVERAGE KRONOS BIO'S
EXPERTISE
IN TRANSCRIPTIONAL REGULATORY NETWORKS AND ITS PROPRIETARY DRUG
DISCOVERY PLATFORM
Source text for Eikon: ID:nGNX8Pn0xB
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems